Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With EGFR-Positive
Clinical trial NCT07712029 · RECRUITING
Trial details
- NCT number
- NCT07712029
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-08-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.